SUPRAX Film-coated tablet Ref.[6586] Active ingredients: Cefixime

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Product name and form

Suprax Tablets 200mg.

Pharmaceutical Form

Convex, off-white, film-coated tablets engraved with ‘ORO’ on one side.

For oral administration.

Qualitative and quantitative composition

Each tablet contains 200mg cefixime (anhydrous).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Cefixime

Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.

List of Excipients

Tablet cores: microcrystalline cellulose, pregelatinised starch, calcium hydrogen phosphate dihydrate and magnesium stearate.

Tablet coating: hypromellose, Macrogol 6000 and titanium dioxide.

Pack sizes and marketing

PVC/aluminium foil blister packs – pack sizes of 1, 2, 7 and 14.

Not all pack sizes may be marketed.

Marketing authorization holder

Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK

Marketing authorization dates and numbers

PL 04425/0623

26 November 2009

Drugs

Drug Countries
SUPRAX Canada, Ireland, Turkey, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.